Soleus Capital Management’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$333K Sell
6,000
-129,000
-96% -$6.94M 0.01% 87
2025
Q4
$6.54M Sell
135,000
-491,040
-78% -$19.1M 0.28% 61
2025
Q3
$19.2M Buy
626,040
+305,000
+95% +$7M 1.02% 29
2025
Q2
$7.13M Buy
321,040
+218,988
+215% +$4.58M 0.49% 47
2025
Q1
$1.9M Sell
102,052
-311,948
-75% -$5.2M 0.15% 63
2024
Q4
$5.48M Buy
+414,000
New +$10M 0.41% 52
2023
Q1
Sell
-14,727
Closed -$456K 78
2022
Q4
$456K Sell
14,727
-49,300
-77% -$1.39M 0.07% 69
2022
Q3
$1.63M Sell
64,027
-579,548
-90% -$13.6M 0.22% 60
2022
Q2
$13.1M Buy
+643,575
New +$14.3M 2.09% 14

Other funds holding ANAB